Based on our recent data which showed that the Aspergillum derived secondary metabolite gliotoxin is a potent NOTCH2/CSL transactivation inhibitor in CLL cells (Hubmann et al., 2013), we tested the effect of gliotoxin in these cell lines. Here, NOTCH2 is linked to B-cell chronic lymphocytic leukemia.